Risk Factors and Complications After Lung Surgery
Author Information
Author(s): Kepičová Markéta, Tulinský Lubomír, Kondé Adéla, Dzurňáková Paula, Ihnát Peter, Adamica Dávid, Neoral Čestmír, Martínek Lubomír
Primary Institution: University Hospital Ostrava
Hypothesis
Does preoperative premedication influence the risk of postoperative pneumonia and overall complications in patients undergoing lobectomy for non-small cell lung cancer?
Conclusion
Premedication does not significantly influence the risk of postoperative pneumonia or overall complications in patients undergoing lobectomy for NSCLC.
Supporting Evidence
- Premedication was not significantly associated with postoperative pneumonia (10.7%) or overall complications (26.0%).
- Larger tumours were linked to higher odds of complications (OR: 1.16, p = 0.032).
- Patients receiving antihistamines had a significantly higher median age than other groups (p < 0.001).
- VATS was associated with a shorter median hospital stay (p = 0.023).
- Postoperative complications occurred in 26.0% of patients.
Takeaway
This study looked at whether giving patients medicine before lung surgery helps prevent problems afterward. It found that the type of medicine didn't really make a difference.
Methodology
This retrospective study analyzed data from 346 patients who underwent lobectomy for NSCLC, focusing on premedication and postoperative outcomes.
Potential Biases
Potential selection bias due to non-randomized allocation of premedication.
Limitations
The study's retrospective design and single-centre nature may limit the generalizability of the findings.
Participant Demographics
The cohort included 212 men (61.3%) and 134 women (38.7%), with a median age of 69 years.
Statistical Information
P-Value
0.032
Confidence Interval
1.16 [1.01–1.32]
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website